Abbott secures CE Mark approval for Tendyne heart valve
Tendyne TMVI system is indicated for treating mitral regurgitation (MR) in patients, who need heart valve replacement and…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
31 Jan 20
Tendyne TMVI system is indicated for treating mitral regurgitation (MR) in patients, who need heart valve replacement and…
31 Jan 20
The new implantable heart devices are compatible with the TriageHF technology
30 Jan 20
CytoSorb has been approved with expanded label indication for the removal of the anti-platelet agent ticagrelor, during cardiopulmonary…
30 Jan 20
VADovations is developing ultra-miniaturized blood pumps designed for minimally invasive and percutaneous, endovascular deployment while addressing the total…
30 Jan 20
Nuance provides intelligent systems that support a more natural and insightful approach to clinical documentation, freeing clinicians to…
29 Jan 20
CorMatrix Cardiovascular, Inc. is a regenerative biotechnology company based in metro Atlanta, Georgia
29 Jan 20
New larger implant enables focal dissection repair across a wider range of vessel sizes
28 Jan 20
The CE mark approval of Vision-MR Ablation Catheter follows the earlier approval of its Advantage-MR EP Recorder/Stimulator System…
27 Jan 20
Neovasc has developed its TF/TS, based on a concept that allows for a very controlled and predictable implantation…
24 Jan 20
The PULSED AF study will assess the safety and effectiveness of the PulseSelect PFA technology to treat atrial…